Nanomol Technologies

Nanomol Technologies focuses on delivering advanced solutions through particle design and nanoformulation. Founded in 2010, the company collaborates with various sectors to enhance drug delivery and healthcare products. Their proprietary DELOS platform is key to their innovative approach, ensuring high-quality development and compliance with industry standards. With a dedicated team of experts, Nanomol is committed…

Nanomol Technologies: Advanced Solutions in Particle Design and Nanoformulation

What Nanomol Technologies Is All About

Nanomol Technologies, S.L. is a privately owned company that’s all about delivering advanced solutions through particle design and nanoformulation. Founded in 2010 by researchers from the Materials Science Institute of Barcelona — CSIC, Nanomol brings together deep expertise in synthesizing and processing molecular functional materials. Located in the Barcelona Autonomous University Research Park, the company thrives on collaboration with academic groups, biotech, pharmaceutical, and chemical industries. Their proprietary DELOS platform is a game-changer for nanoformulation and drug delivery, adding real value to drugs and healthcare products across pharmaceuticals, cosmetics, biocides, and medical devices.

The Main Benefit: Innovation and Advanced Technology

Nanomol’s core strength lies in innovation and cutting-edge technology platforms. Here’s what sets them apart:

  • Innovation: Particle design tailored for pharma, biotech, and healthcare products.
  • Advanced Technology Platforms: Producing particles with outstanding properties that push boundaries.
  • Particle Characterization: High-value services analyzing APIs, intermediates, and final products.
  • Passion: A genuine drive for developing and characterizing nanomedicines and particulate products.
  • High Quality Development and Analysis: Following GMP, ICH, Ph.Eur., USP, and ISO standards rigorously.
  • Highly Qualified Team: Experienced professionals ready to be your best R+D partner.
  • Environmental Commitment: Technologies designed to create better healthcare products responsibly and sustainably.

The Team Behind the Innovation

Nanomol’s strength also comes from its people. The team is a mix of seasoned experts and fresh talent, all passionate about pushing the limits of nanomedicine and particle technology. Dr. Lidia Ferrer leads R&D, overseeing experimental design and evaluation. Business development and tech transfer are in the capable hands of Dr. Alba Córdoba. The Particle Analysis Unit is managed by Òscar Raposo, while process engineering is handled by Josep Merlo. Lab management and R&D science are driven by Carla Castellar, with support from scientists like Marta Alcaina, Arnau Güell, and Estela Álvarez, who specializes in physicochemical characterization under GMP compliance. Quality assurance is managed by Laura Gonzalez, and the team also includes promising newcomers like Sandra, fresh from her Pharmacy degree, and Sara, bringing expertise in pharmaceutical manufacturing and quality control.

Leadership and Vision

At the helm, Dr. Santi Sala, CEO and cofounder, steers the company’s strategy, finance, business development, marketing, and sales. The scientific backbone is strengthened by Senior Scientific Consultants and cofounders Prof. Jaume Veciana and Dr. Nora Ventosa, whose guidance ensures Nanomol stays at the forefront of particle technology innovation.

Commitment to Quality and Compliance

Quality is not just a buzzword at Nanomol. The company rigorously follows GMP, ICH, Ph.Eur., USP, and ISO guidelines to ensure every particle and product meets the highest standards. This commitment guarantees that their clients receive reliable, reproducible, and safe products, whether it’s raw materials, intermediates, or final formulations. The team’s expertise in particle characterization and process engineering supports this high bar, making Nanomol a trusted partner in the healthcare sector.

Impact on Sustainable Development Goals (SDGs)

  • Good Health and Well-being (SDG 3): Enhancing drug delivery and healthcare products.
  • Industry, Innovation, and Infrastructure (SDG 9): Developing advanced technology platforms.
  • Responsible Consumption and Production (SDG 12): Commitment to environmentally responsible technologies.
  • Partnerships for the Goals (SDG 17): Collaborating with academic, biotech, pharmaceutical, and chemical sectors.

How to Connect with Nanomol Technologies

Located in the vibrant research environment of the UAB Campus in Bellaterra, Barcelona, Nanomol Technologies is easy to reach. For inquiries or collaborations, they can be contacted via email at info@nanomol-tech.com or by phone at +34 935 868 963. Stay updated and connected through their social media channels on Twitter and LinkedIn. Whether you’re curious about their latest innovations or looking to partner up, Nanomol is just a message away.

Discover other innovative projects :

Learn more about the Sustainable Development Goals :